MedWatch

Streamlining to ensure success for ALK: "We need a solid foundation"

Danish allergy group ALK has invested more efforts than ever in simplifying processes and streamlining the company. The changes involve expenses in the short-term but will hopefully help ALK fulfill the long-term goal to match other pharma companies.

Carsten Hellmann, CEO, ALK Photo: Gregers Tycho/ERH

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles